NextCure, Inc. (NXTC) Operating cash flow 2018–2025
NextCure, Inc. (NXTC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$49.6MFY2025 · since FY2018: $8.0M → -$49.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.6M | -21.6% |
| FY2024 | -$40.8M | +23.0% |
| FY2023 | -$53.0M | +1.7% |
| FY2022 | -$53.9M | +5.9% |
| FY2021 | -$57.3M | -27.4% |
| FY2020 | -$45.0M | -26.2% |
| FY2019 | -$35.6M | -545.7% |
| FY2018 | $8.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice